Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MaPS in ENL
NCT03775460Active, not recruiting
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jan 2023
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
Randomised, double-blind trial in erythema nodosum leprosum (ENL) comparing Methotrexate + Prednisolone with Placebo + Prednisolone (2 arms). Primary endpoint: Proportion of individuals free from Erythema Nodosum Leprosum (ENL) flares at 48 weeks. Started Jan 2023; status: active, not recruiting.
02
Drugs
methotrexate
03
Conditions
erythema nodosum leprosum (ENL)
Beyond the preview
Go deeper on NCT03775460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03775460.